Development of a Molecular Assay for Rapid Screening of Chemopreventive Compounds Targeting Nrf2

被引：0
|
作者：
Wang, Zhaohui [1 ]
Gidwani, Vinay [1 ]
Sun, Zheng [1 ]
Zhang, Donna D. [1 ]
Wong, Pak Kin [1 ]
机构：
[1] University of Arizona, Tucson, AZ, United States
来源：
JALA - Journal of the Association for Laboratory Automation | 2008年 / 13卷 / 04期
关键词：
This work was supported by the Johns Hopkins Center for Alternatives to Animal Testing (2008-17) and the Arizona Cancer Center Support Grant (CA23074). Z. Wang is partially supported by the Bio5 Biology; Mathematics; and Physics Initiative (BMPI) Scholarship Award;
D O I：
10.1016/j.jala.2008.03.007
中图分类号：
学科分类号：
摘要：
22
引用
收藏
页码：243 / 248
相关论文
共 50 条
  • [21] Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
    Olayanju, Adedamola
    Copple, Ian M.
    Bryan, Holly K.
    Edge, George T.
    Sison, Rowena L.
    Wong, Min Wei
    Lai, Zheng-Quan
    Lin, Zhi-Xiu
    Dunn, Karen
    Sanderson, Christopher M.
    Alghanem, Ahmad F.
    Cross, Michael J.
    Ellis, Ewa C.
    Ingelman-Sundberg, Magnus
    Malik, Hassan Z.
    Kitteringham, Neil R.
    Goldring, Christopher E.
    Park, B. Kevin
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 78 : 202 - 212
  • [22] Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
    Iida, K
    Itoh, K
    Kumagai, Y
    Oyasu, R
    Hattori, K
    Kawai, K
    Shimazui, T
    Akaza, H
    Yamamoto, M
    CANCER RESEARCH, 2004, 64 (18) : 6424 - 6431
  • [23] NRF2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
    Iida, K
    Itoh, K
    Kumagai, Y
    Oyasu, R
    Hattori, K
    Kawai, K
    Shimazui, T
    Akaza, H
    Yamamoto, M
    JOURNAL OF UROLOGY, 2005, 173 (04): : 208 - 208
  • [24] The Role of Nrf2 in Glioma: Therapeutic Targeting Strategies
    Harifi-Mood, Mohammad Sadra
    Alemzadeh, Effat
    Barati, Danyal
    Dehghani, Amir Hossein
    Siroosi, Fatemeh Zahra
    Aschner, Michael
    Samini, Fariborz
    Samarghandian, Saeed
    Farkhondeh, Tahereh
    CURRENT CANCER DRUG TARGETS, 2025,
  • [25] Targeting constitutively overexpressed NRF2 in esophageal adenocarcinoma
    Peng, Dunfa
    Lu, Heng
    Hu, Tianling
    Sriramajayam, Kannappan
    El-Rifai, Wael
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Targeting NRF2 to suppress ferroptosis in brain injury
    Song, Shunchen
    Gao, Yaxuan
    Sheng, Yi
    Rui, Tongyu
    Luo, Chengliang
    HISTOLOGY AND HISTOPATHOLOGY, 2021, 36 (04) : 383 - 397
  • [27] Targeting Nrf2 with Probiotics and Postbiotics in the Treatment of Periodontitis
    Karaca, Basar
    Yilmaz, Mustafa
    Gursoy, Ulvi Kahraman
    BIOMOLECULES, 2022, 12 (05)
  • [28] Targeting the Nrf2 pathway against cardiovascular disease
    Li, Jinqing
    Ichikawa, Tomonaga
    Janicki, Joseph S.
    Cui, Taixing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 785 - 794
  • [29] THERAPEUTIC TARGETING OF NRF2 IN ALZHEIMER'S DISEASE
    Carnicero-Senabre, Daniel
    Barata, Mariana A.
    Almeida, Claudia Guimas
    Cuadrado, Antonio
    Rojo, Ana I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 218 : 3 - 3
  • [30] Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
    Kourakis, Stephanie
    Timpani, Cara A.
    de Haan, Judy B.
    Gueven, Nuri
    Fischer, Dirk
    Rybalka, Emma
    REDOX BIOLOGY, 2021, 38
12345